I'm sorry, but no one has done their job, and that includes us. You stated in your submissions that the government had failed to put in place the necessary infrastructure. Companies have not managed to test one fully. I'm telling you to test three. That's all I wish to say on the subject.
If I understood you correctly, Mr. Alton, your pharmaceutical product will cost an average of $240 in disadvantaged countries where the gross per capita income is $825. And we're not even talking about the world's poorest nations. That would be like someone paying $12,000 for drugs in Canada, on an annual income of $40,000. Can anyone in Africa afford this kind of drug?